30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

NeOnc Technologies Holdings Inc (NTHI)

Track

Over the last 90 days, NeOnc Technologies Holdings Inc. has seen significant insider buying, with a net value of $423,560. Three executives were involved, all making purchases. Notably, President Heshmatpour Amir F made multiple buy transactions totaling over $300,000. No insider selling was reported during this period. The stock has experienced a 33.1% price decrease over the past 90 days.
Stock chart
Ticker: NTHI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Heshmatpour Amir F
President
1 purchase — total 41,592 USD
Buy 1 May 2026
Value US$2,361,397.59 | Price 149.44 | Shares 29,630
Buy 28 Apr 2026
Value US$4,162,580.65 | Price 243.27 | Shares 62,027
Buy 23 Apr 2026
Value US$2,440.00 | Price 4.88 | Shares 500
Buy 23 Apr 2026
Value US$49,000.00 | Price 4.90 | Shares 10,000
Buy 10 Apr 2026
Value US$48,950.00 | Price 4.90 | Shares 10,000
Buy 9 Apr 2026
Value US$1,000.00 | Price 5.00 | Shares 200
Buy 9 Apr 2026
Value US$25,950.00 | Price 5.19 | Shares 5,000
Buy 8 Apr 2026
Value US$56,050.00 | Price 5.61 | Shares 10,000
Buy 6 Apr 2026
Value US$31,600.00 | Price 6.32 | Shares 5,000
Buy 2 Apr 2026
Value US$121,798.00 | Price 6.09 | Shares 20,000
Buy 24 Nov 2025
Value US$39,060.00 | Price 6.51 | Shares 6,000
Buy 21 Nov 2025
Value US$26,000.00 | Price 6.50 | Shares 4,000
Buy 21 Nov 2025
Value US$119,600.00 | Price 5.98 | Shares 20,000
Buy 20 Nov 2025
Value US$7,359.00 | Price 6.69 | Shares 1,100
Buy 23 May 2025
Value US$14,785.00 | Price 7.39 | Shares 2,000
Buy 22 May 2025
Value US$20,000.01 | Price 7.38 | Shares 2,709
Buy 22 May 2025
Value US$4,920.75 | Price 7.29 | Shares 675
Buy 21 May 2025
Value US$20,002.47 | Price 7.25 | Shares 2,759
Buy 19 May 2025
Value US$976.05 | Price 7.23 | Shares 135
Buy 16 May 2025
Value US$59,221.07 | Price 16.87 | Shares 3,510
Buy 15 May 2025
Value US$10,945.05 | Price 7.30 | Shares 1,500
Buy 14 May 2025
Value US$7,267.00 | Price 7.27 | Shares 1,000
Buy 13 May 2025
Value US$6,941.78 | Price 7.01 | Shares 990
Buy 12 May 2025
Value US$36,110.00 | Price 7.22 | Shares 5,000
Buy 12 May 2025
Value US$2,800.00 | Price 7.00 | Shares 400
Buy 12 May 2025
Value US$10,123.96 | Price 7.23 | Shares 1,400
Buy 11 May 2025
Value US$12,016.00 | Price 7.51 | Shares 1,600
Buy 17 Apr 2025
Value US$346.00 | Price 6.92 | Shares 50
Buy 15 Apr 2025
Value US$1,614.00 | Price 5.38 | Shares 300
Buy 26 Mar 2025
Value US$802.30 | Price 16.05 | Shares 50
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-04 2026-05-01 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
29,630 -1.7%
149.44
US$2,361,398 		29,630 -1.7% 149.44 US$2,361,398
2026-04-28 2026-04-28 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
62,027 +49.4%
243.27
US$4,162,581 		62,027 +49.4% 243.27 US$4,162,581
2026-04-24 2026-04-23 B Purchase
3.3
Neman-Ebrahim Yousha

Chief Clinical Officer

Officer
37,296 +49.3%
81.69
US$295,625 		37,296 +49.3% 81.69 US$295,625
2026-04-23 2026-04-23 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
10,000 +0.3%
4.90
US$49,000 		10,000 +0.3% 4.90 US$49,000
2026-04-10 2026-04-10 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
10,000 +0.3%
4.90
US$48,950 		10,000 +0.3% 4.90 US$48,950
2026-04-13 2026-04-09 B Purchase
SUH, DAVID JR.

Chief Accounting Officer

Officer
200 +0.2%
5.00
US$1,000 		200 +0.2% 5.00 US$1,000
2026-04-09 2026-04-09 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
5,000 +0.2%
5.19
US$25,950 		5,000 +0.2% 5.19 US$25,950
2026-04-09 2026-04-08 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
10,000 +0.3%
5.61
US$56,050 		10,000 +0.3% 5.61 US$56,050
2026-04-06 2026-04-06 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
5,000 +0.2%
6.32
US$31,600 		5,000 +0.2% 6.32 US$31,600
2026-04-06 2026-04-02 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
20,000 +0.7%
6.09
US$121,798 		20,000 +0.7% 6.09 US$121,798
2025-11-24 2025-11-24 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
6,000 +0.2%
6.51
US$39,060 		6,000 +0.2% 6.51 US$39,060
2025-11-24 2025-11-21 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
4,000 +0.1%
6.50
US$26,000 		4,000 +0.1% 6.50 US$26,000
2025-11-24 2025-11-21 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director Large shareholder
20,000 +0.7%
5.98
US$119,600 		20,000 +0.7% 5.98 US$119,600
2025-11-24 2025-11-20 B Purchase
3.3
Neman-Ebrahim Yousha

Chief Clinical Officer

Officer
1,100 +0.8%
6.69
US$7,359 		1,100 +0.8% 6.69 US$7,359
2025-05-23 2025-05-23 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
2,000 +0.1%
7.39
US$14,785 		2,000 +0.1% 7.39 US$14,785
2025-05-23 2025-05-22 B Purchase
1.8
CHEN THOMAS C

CEO

Executive Director Large shareholder
2,709 +0.5%
7.38
US$20,000 		2,709 +0.5% 7.38 US$20,000
2025-05-23 2025-05-22 B Purchase
1.8
GARNETT KEITHLY

CFO

Officer
675 +0.3%
7.29
US$4,921 		675 +0.3% 7.29 US$4,921
2025-05-23 2025-05-21 B Purchase
1.8
CHEN THOMAS C

CEO

Executive Director Large shareholder
2,759 +0.5%
7.25
US$20,002 		2,759 +0.5% 7.25 US$20,002
2025-05-22 2025-05-19 B Purchase
1.8
GARNETT KEITHLY

CFO

Officer
135 +0.1%
7.23
US$976 		135 +0.1% 7.23 US$976
2025-05-19 2025-05-16 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
3,510 +0.2%
16.87
US$59,221 		3,510 +0.2% 16.87 US$59,221
2025-05-19 2025-05-15 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
1,500 +0.1%
7.30
US$10,945 		1,500 +0.1% 7.30 US$10,945
2025-05-19 2025-05-14 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
1,000 +0.1%
7.27
US$7,267 		1,000 +0.1% 7.27 US$7,267
2025-05-19 2025-05-13 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
990 +0.1%
7.01
US$6,942 		990 +0.1% 7.01 US$6,942
2025-05-19 2025-05-12 B Purchase
2.0
Delshad Jim
Non-Executive Director
5,000 +9.9%
7.22
US$36,110 		5,000 +9.9% 7.22 US$36,110
2025-05-19 2025-05-12 B Purchase
1.8
CHEN THOMAS C

CEO

Executive Director Large shareholder
400 +0.1%
7.00
US$2,800 		400 +0.1% 7.00 US$2,800
2025-05-19 2025-05-12 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
1,400 +0.1%
7.23
US$10,124 		1,400 +0.1% 7.23 US$10,124
2025-05-19 2025-05-11 B Purchase
3.5
Heshmatpour Amir F

President

Executive Director
1,600 +0.1%
7.51
US$12,016 		1,600 +0.1% 7.51 US$12,016
2025-05-19 2025-04-17 B Purchase
2.0
Delshad Jim
Non-Executive Director
50 +0.1%
6.92
US$346 		50 +0.1% 6.92 US$346
2026-04-24 2025-04-15 B Purchase
1.8
GARNETT KEITHLY

CFO

Officer
300 +0.1%
5.38
US$1,614 		300 +0.1% 5.38 US$1,614
2025-05-19 2025-03-26 B Purchase
2.0
Delshad Jim
Non-Executive Director
50 +0.1%
16.05
US$802 		50 +0.1% 16.05 US$802
Explore more

More insider trading research around NeOnc Technologies Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America